Comprehensive Study of Antiretroviral Drug Permeability at the Cervicovaginal Mucosa <i>via</i> an In Vitro Model
Modulation of drug transporter activity at mucosal sites of HIV-1 transmission may be exploited to optimize retention of therapeutic antiretroviral drug concentrations at target submucosal CD4+ T cells. Previously, we showed that darunavir was a substrate for the P-glycoprotein efflux drug transport...
Saved in:
Main Authors: | Constandinos Carserides (Author), Kieron Smith (Author), Marta Zinicola (Author), Abhinav Kumar (Author), Magda Swedrowska (Author), Carlo Scala (Author), Gary Cameron (Author), Zoe Riches (Author), Francesco Iannelli (Author), Gianni Pozzi (Author), Georgina L. Hold (Author), Ben Forbes (Author), Charles Kelly (Author), Karolin Hijazi (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Increased vascularity in cervicovaginal mucosa with Schistosoma haematobium infection.
by: Peter Mark Jourdan, et al.
Published: (2011) -
The Role of Cationic Polypeptides in Modulating HIV-1 Infection of the Cervicovaginal Mucosa
by: Amy Liese Cole, et al.
Published: (2014) -
Permeability of Buccal Mucosa
by: Apipa Wanasathop, et al.
Published: (2021) -
Ligneous Cervicovaginitis
by: Sunduz Ozlem Altinkaya, et al.
Published: (2008) -
Oral Mucosa Models to Evaluate Drug Permeability
by: Elena Mazzinelli, et al.
Published: (2023)